Zegerid acid reflux drug yields positive clinical results

01/7/2008 | Boston Globe (tiered subscription model), The

A study on the effect of morning dosing on 24-hour gastric-acid control in patients with symptoms of gastroesophageal reflux disease showed that Zegerid helped patients maintain a gastric pH level of more than 4. The test subjects were able to sustain that level about 43% longer than patients taking Protonix, and 22% longer than those taking Prevacid, the report said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA